Cookies on this site

Most children with a severely broken wrist can be treated without surgery, according to a major NIHR-funded UK trial led by researchers at the University of Oxford. The findings suggest that a non-surgical, cast-first approach delivers similar long-term recovery while reducing the risks associated with surgery and costs.

A young girl dressed with a cape and with a white bandage on her left arm © Canva

Broken wrists are among the most common injuries in children accounting for about half of children's fractures. Severely displaced distal radial fractures, where the bones move out of place, are often routinely treated with surgery. However – unlike adults - children have a remarkable ability to straighten broken bones, in a process called remodelling.

Researchers questioned whether a plaster cast would achieve the same long-term result without exposing children to the risks of an operation.

Professor Matt Costa, senior author and Professor, Orthopaedics Trauma Surgery at the Kadoorie Institute, University of Oxford said: 'These fractures can look very severe on an X-ray, which has traditionally led to surgery to straighten the bone. But because children's bones are still growing, they have a remarkable capacity to heal. Until now, there has been limited high-quality evidence on whether surgery was always necessary.'

The CRAFFT trial (Children's Radius Acute Fracture Fixation Trial) was funded by the National Institute for Health and Care Research (NIHR) and supported by the NIHR Biomedical Research Centre: Oxford. It recruited 750 children aged 4–10 from 49 hospitals across the UK. Participants were randomly assigned to receive either surgical fixation or treatment with a plaster cast.

Patients were measured at regular intervals against a set of criteria. At three months, children who had surgery reported slightly better arm function, but the difference between groups was very small. By six and 12 months, there was no difference in recovery, suggesting that early advantages with surgery do not persist.

There were complications following surgery, including infections, scarring and nerve irritation. Non-surgical treatment, which avoids anaesthesia and operative intervention, was shown to reduce NHS costs by around £1,600 per patient on average.

The trial was designed with input from families, who helped define what level of improvement would be meaningful enough to warrant surgery. The observed difference between treatments fell below this threshold.

Professor Dan Perry, NIHR Research Professor and Children's Orthopaedic Surgeon at Alder Hey Children's Hospital and the University of Liverpool, and lead author, said: 'It is astonishing that children have the ability to grow bent, broken bones straight again. It really is a superpower that is unique to children. From both a clinical and health system perspective, these findings are important. Adoption of these results could reduce the number of children exposed to the risks of anaesthesia and surgery, and ease pressure on healthcare services without compromising recovery.'

The results, published in The Lancet, support wider adoption of a cast-first approach for most children with these injuries.

Similar stories

New platform improves accuracy of molecular counting in RNA-sequencing

Researchers at NDORMS have developed a new computational platform to improve the accuracy of molecular counting in RNA-sequencing, helping scientists generate more reliable data for genetic research.

Professor Menna Clatworthy to join the Kennedy Institute at NDORMS

Professor Menna Clatworthy, recently announced as the new Regius Professor of Medicine at the University of Oxford, will join the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) as a Principal Investigator at the Kennedy Institute of Rheumatology with effect from March 2027. Professor Clatworthy will also join the Nuffield Department of Surgical Sciences highlighting the breadth and relevance of her research to multiple medical departments in Oxford.

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.